// App-Quantinova.ai

: Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial

Researchers

Presenter

  • Sanjay Ramakrishnan

Principal Investigators

  • Beverly Langford

  • Mahdi Mahdi

  • Helen Jeffers

  • Christine Mwasuku

  • Karolina Krassowska

  • Robin Fox

  • Ian Binnian

  • Victoria Glover

  • Stephen Bright

  • Christopher Butler

  • Jennifer Cane

  • Andreas Halner

  • Philippa C Matthews

  • Louise E Donnelly

  • Jodie L Simpson

  • Jonathan R Baker

  • Nabil T Fadai

  • Stefan Peterson

  • Thomas Bengtsson

  • Peter J Barnes

  • Richard E K Russell

  • Mona Bafadhel

Medical Centers

  • University of Oxford, Oxford, United Kingdom

  • STATMIND, Lund, Sweden

  • Windrush Medical Practice, Windrush, United Kingdom

  • Bicester Health Centre, Bicester, United Kingdom

  • Eynsham Medical Centre, Eynsham, United Kingdom

  • National Heart and Lung Institute, London, United Kingdom

  • White Horse Medical Practice, Faringdon, United Kingdom

  • University of Nottingham, Nottingham, United Kingdom

  • University of Newcastle, Newcastle, New South Wales, Australia

Locations

  • Sweden

  • United Kingdom

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Budesonide

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

  • Controlled

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved